COVID-19: Remdesivir included as ‘investigational therapy’ only for restricted emergency use, clarifies Health Ministry

An updated Clinical Management Protocol for COVID-19 has been released by the Ministry of Health and Family Welfare on 13 June 2020 in which the drug Remdesivir has been included as an “investigational therapy” only for restricted emergency use purposes along with off label use of Tocilizumab and Convalescent Plasma.